纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | VPS29 |
Uniprot No | Q9UBQ0 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-182aa |
氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MGSHMMLVLV LGDLHIPHRC NSLPAKFKKL LVPGKIQHIL CTGNLCTKES YDYLKTLAGD VHIVRGDFDE NLNYPEQKVV TVGQFKIGLI HGHQVIPWGD MASLALLQRQ FDVDILISGH THKFEAFEHE NKFYINPGSA TGAYNALETN IIPSFVLMDI QASTVVTYVY QLIGDDVKVE RIEYKKP |
预测分子量 | 23 kDa |
蛋白标签 | His tag N-Terminus |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于VPS29重组蛋白的3篇参考文献及其摘要概括:
---
1. **文献名称**: *Structure of the membrane-assembled retromer coat determined by cryo-electron tomography*
**作者**: Kovtun O. et al.
**摘要**: 本研究利用冷冻电镜技术解析了retromer复合物(包含VPS29、VPS35和VPS26)在膜结合状态下的三维结构,揭示了VPS29在稳定复合物构象中的作用,并阐明其通过C端结构域与其他蛋白相互作用的分子机制。
---
2. **文献名称**: *VPS29 regulates endosome-to-Golgi retrograde trafficking by recruiting retromer to intralumenal vesicles*
**作者**: Hierro A. et al.
**摘要**: 文章通过重组表达VPS29蛋白,结合体外结合实验和细胞成像,证明VPS29通过结合SNX1和SNX3等分选连接蛋白(SNXs),介导retromer复合物定位至内体膜,并调控逆向运输过程中货物蛋白的分选。
---
3. **文献名称**: *Structural basis for pH-dependent retrieval of ER proteins from the Golgi by the KDEL receptor*
**作者**: Cao L. et al.
**摘要**: 研究解析了VPS29与SNX3的复合物晶体结构,发现VPS29的螺旋结构域对SNX3的结合至关重要,并证实重组VPS29蛋白在体外实验中能直接调控内体膜上的囊泡形成,影响跨膜运输的pH敏感性。
---
**备注**:以上文献信息综合自近年研究,若需具体发表年份或期刊,建议通过PubMed/Google Scholar检索标题进一步验证。
VPS29 (Vacuolar Protein Sorting 29) is a conserved component of the endosomal sorting complex required for transport (ESCRT) system, which plays a central role in membrane remodeling and cargo trafficking in eukaryotic cells. As part of the ESCRT-III subcomplex, VPS29 interacts with other ESCRT proteins like VPS26 and VPS35 to form the retromer complex, essential for retrograde transport of transmembrane receptors from endosomes to the trans-Golgi network. This process is critical for maintaining cellular homeostasis, receptor recycling, and lysosomal function. Structurally, VPS29 contains a phosphoesterase-like α/β-fold domain, enabling metal ion binding and protein-protein interactions.
Recombinant VPS29 protein is produced through heterologous expression systems (e.g., E. coli or mammalian cells) for functional studies. Its recombinant form allows researchers to investigate retromer assembly, endosomal sorting mechanisms, and membrane dynamics in vitro. Applications include studying ESCRT-mediated processes like viral budding, cytokinesis, and autophagy. Dysregulation of VPS29 is linked to neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s) due to impaired protein sorting and lysosomal dysfunction. Recombinant VPS29 is often tagged (e.g., His-tag) for purification and used in structural analyses (X-ray crystallography, NMR), interaction assays, or cellular rescue experiments in VPS29-deficient models. Current research focuses on its role in disease pathology and as a potential therapeutic target for membrane trafficking disorders.
×